Innovating Works

SEQUENTIA BIOTECH

Activa
MICK: Translational Microbiome Platform SEQUENTIA BIOTECH tramitó un HORIZON EUROPE: Dysbiosis (the imbalance of the microbial community that resides within and upon us) can affect health and represents a risk factor for the genesis and evolution of a plethora of chronic diseases and...
2022-08-31 | Financiado
SUMOCell: Study of molecular events triggering the cytosolic enrichment of SUMO activating enzyme and its implications in seed quality. CENTRE RECERCA EN AGRIGENOMICA CSIC IRTA UAB UB CRAG tramitó un HORIZON EUROPE: Post-translational modifications by SUMO (Small Ubiquitin-like MOdifier) modulate protein activity through regulation of subcellular localization, protein activity and stability, and protein-protein i...
2022-05-09 | Financiado
POLYPLOID: THE POLYPLOIDY PARADIGM AND ITS ROLE IN PLANT BREEDING UNIVERSITA DEGLI STUDI DI PERUGIA tramitó un H2020: Polyploidization is a major force in the evolution of both wild and cultivated plants. The remarkable superiority of polyploids has been noticed plant breeders, who have used this trait in different a...
2021-04-01 | Financiado
GAIA-Health: GAIA-Health: microbiome suite for personalized medicine SEQUENTIA BIOTECH tramitó un H2020: GAIA-Health: microbiome suite for personalized medicineGenomic revolution is transforming our approach to treat patients by individualizing treatments that reduce adverse events and in turn decrease h...
2019-06-01 | Financiado
AIR: Artificial Intelligence RNA-seq SEQUENTIA BIOTECH tramitó un H2020: We propose a disruptive ICT concept strictly connected to SMEInst: Open Disruptive Innovation Scheme. In the field of genomics, sequencing technologies have drastically changed in the last few years a...
2017-03-01 | Financiado
DI-17-09652: Herramientas genómicas en la nube: la nueva frontera para los análisis de datos ómicos SEQUENTIA BIOTECH tramitó un AEI: 2017-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.